42 U.S.C. · The Public Health and Welfare
42 U.S.C. § 1320a7i

Reporting of information relating to drug samples

Ch. 7 — SOCIAL SECURITY
Title 42 U.S.C. ● ACTIVE Primary Source Ch. 7
Statutory Text

42 U.S.C. § 1320a7i — Reporting of information relating to drug samples

U.S.C. Title 42 - THE PUBLIC HEALTH AND WELFARE 42 U.S.C. United States Code, 2023 Edition Title 42 - THE PUBLIC HEALTH AND WELFARE CHAPTER 7 - SOCIAL SECURITY SUBCHAPTER XI - GENERAL PROVISIONS, PEER REVIEW, AND ADMINISTRATIVE SIMPLIFICATION Part A - General Provisions Sec. 1320a-7i - Reporting of information relating to drug samples From the U.S. Government Publishing Office, www.gpo.gov

§1320a–7i. Reporting of information relating to drug samples

(a) In general Not later than April 1 of each year (beginning with 2012), each manufacturer and authorized distributor of record of an applicable drug shall submit to the Secretary (in a form and manner specified by the Secretary) the following information with respect to the preceding year: (1) In the case of a manufacturer or authorized distributor of record which makes distributions by mail or common carrier under subsection (d)(2) of section 353 of title 21, the identity and quantity of drug samples requested and the identity and quantity of drug samples distributed under such subsection during that year, aggregated by— (A) the name, address, professional designation, and signature of the practitioner making the request under subparagraph (A)(i) of such subsection, or of any individual who makes or signs for the request on behalf of the practitioner; and (B) any other category of information determined appropriate by the Secretary.

(2) In the case of a manufacturer or authorized distributor of record which makes distributions by means other than mail or common carrier under subsection (d)(3) of such section 353 of title 21, the identity and quantity of drug samples requested and the identity and quantity of drug samples distributed under such subsection during that year, aggregated by— (A) the name, address, professional designation, and signature of the practitioner making the request under subparagraph (A)(i) of such subsection, or of any individual who makes or signs for the request on behalf of the practitioner; and (B) any other category of information determined appropriate by the Secretary. (b) Definitions In this section: (1) Applicable drug The term "applicable drug" means a drug— (A) which is subject to subsection (b) of such section 353 of title 21; and (B) for which payment is available under subchapter XVIII or a State plan under subchapter XIX or XXI (or a waiver of such a plan). (2) Authorized distributor of record The term "authorized distributor of record" has the meaning given that term in subsection (e)(3)(A) of such section. (3) Manufacturer The term "manufacturer" has the meaning given that term for purposes of subsection (d) of such section.

(Aug. 14, 1935, ch. 531, title XI, §1128H, as added Pub. L. 111–148, title VI, §6004, Mar. 23, 2010, 124 Stat. 697.)

Source: uscode.house.gov — public domain Official Source ↗
Root-LD Entity Data
◈ Machine-Readable Provenance Record Root-LD v1.0 · boisestandard.org
Federation ID
BS-USC42-SEC-C7A6F1
Entity Class
STATUTE / FEDERAL-CODE-SECTION
Domain Signature
boisestandard.org
Citation
42 U.S.C. § 1320a7i
Jurisdiction
Federal — United States
Status
✓ ACTIVE
Source
PRIMARY-SOURCE
Source Verified
✓ TRUE
Content Hash
0bba64d7799eea59...
Semantic Edges
Pending — corpus passes queued
The statutory text of 42 U.S.C. § 1320a7i is reproduced from the official United States Code as published by the Office of the Law Revision Counsel of the U.S. House of Representatives (uscode.house.gov).
Navigate Corpus — Title 42
◈ Provenance
boisestandard.org United States Law U.S. Code Title 42 42 U.S.C. § 1320a7i